￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest market prices and trends of Teclistamab-cqyv

2026-02-01 22:25:32

Check Details
Pharmacological introduction to the FLT3 inhibitor Quizartinib

2026-02-01 22:25:32

Check Details
Is pomalidomide included in medical insurance?

2026-02-01 22:25:32

Check Details
Dosage and usage of Remibrutinib-RHAPSIDO

2026-02-01 22:25:32

Check Details
What is the average resistance period to lapatinib/telisate?

2026-02-01 22:25:32

Check Details
What is the difference between filgotinib and upadatinib

2026-02-01 22:25:32

Check Details
Is Trientine included in medical insurance?

2026-02-01 22:25:32

Check Details
Mirikizumab price and formal purchase channels

2026-02-01 22:25:32

Check Details
Is there an Indian version of Selumetinib?

2026-02-01 22:25:32

Check Details
Lorlatinib/lorlatinib’s launch time and market response

2026-02-01 22:25:32

Check Details
FDA approves Remibrutinib-RHAPSIDO to treat chronic spontaneous urticaria

2026-02-01 22:25:32

Check Details
A must-read for patients with BRAF mutations: Trametinib’s latest efficacy, medication key points and price analysis

2026-02-01 22:25:32

Check Details
Category
相关知识